Achieve Life Sciences (ACHV) Receivables - Net (2010 - 2019)

Achieve Life Sciences (ACHV) has 13 years of Receivables - Net data on file, last reported at $111000.0 in Q4 2023.

• Quarterly Receivables - Net rose 5.71% year-over-year to $111000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $111000.0 (up 5.71% YoY) and the FY2023 annual result came in at $111000.0, up 5.71% from the prior year.
• Receivables - Net rose to $111000.0 in Q4 2023, from $83000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $350000.0 in Q2 2023 to a low of $8000.0 in Q4 2019.
• A 4-year average of $150800.0 and a median of $128000.0 in 2022 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2019 — Receivables - Net increased 14.29% — and 2023, when it tumbled 42.76%.
• Tracing ACHV's Receivables - Net over 4 years: stood at $8000.0 in 2019, then soared by 1812.5% to $153000.0 in 2021, then slumped by 31.37% to $105000.0 in 2022, then increased by 5.71% to $111000.0 in 2023.
• The last three Receivables - Net figures came in at $111000.0 (Q4 2023), $83000.0 (Q3 2023), and $350000.0 (Q2 2023), per Business Quant data.